High plasma growth hormone (GH) levels inhibit expression of GH secretagogue receptor messenger ribonucleic acid levels in the rat pituitary

Ralf Nass, Joan Gilrain, Stacey Anderson, Bruce Gaylinn, Alan Dalkin, Richard Day, Mario Peruggia, Michael O. Thorner

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Synthetic GH secretagogues (GHSs) act via a receptor (GHS-R) distinct from that of GH-releasing hormone. The GHS-R has been cloned from the pituitary and is expressed not only in the pituitary but also in specific areas of the brain, including the hypothalamus. Recent studies suggest that hypothalamic GHS-R expression is regulated by GH. This study was designed to investigate whether pituitary GHS-R expression is modulated by GH. Female Wistar-Furth rats were injected sc with either saline (control) or GC tumor cells (GC) that secrete rat GH. The tumors were allowed to develop for 1-4 weeks. At weeks 1-4, control (n = 4-8) and GC rats (n = 3-8) were killed. Pituitary GHS-R messenger RNA (mRNA) was measured by a quantitative competitive PCR assay. The endogenous GHS-R mRNA levels were measured by determining the amount of competitive template RNA required to produce equimolar amounts of native and competitive template PCR products. The mean log plasma GH levels were significantly greater in the GC rat group than in the control group at weeks 2, 3, and 4. At these times, the mean log pituitary GHS-R mRNA contents were significantly lower in the GC rat group than in the control group. No relationship could be established between log estradiol levels and GHS-R levels. These data indicate that pituitary GHS-R expression is modulated by GH.

Original languageEnglish (US)
Pages (from-to)2084-2089
Number of pages6
JournalEndocrinology
Volume141
Issue number6
DOIs
StatePublished - 2000
Externally publishedYes

Fingerprint

Ghrelin Receptor
Growth Hormone
RNA
Messenger RNA
Inbred WF Rats
Growth Hormone-Releasing Hormone
Polymerase Chain Reaction
Control Groups
Hypothalamus
Estradiol
Neoplasms
Brain

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Cite this

High plasma growth hormone (GH) levels inhibit expression of GH secretagogue receptor messenger ribonucleic acid levels in the rat pituitary. / Nass, Ralf; Gilrain, Joan; Anderson, Stacey; Gaylinn, Bruce; Dalkin, Alan; Day, Richard; Peruggia, Mario; Thorner, Michael O.

In: Endocrinology, Vol. 141, No. 6, 2000, p. 2084-2089.

Research output: Contribution to journalArticle

Nass, Ralf ; Gilrain, Joan ; Anderson, Stacey ; Gaylinn, Bruce ; Dalkin, Alan ; Day, Richard ; Peruggia, Mario ; Thorner, Michael O. / High plasma growth hormone (GH) levels inhibit expression of GH secretagogue receptor messenger ribonucleic acid levels in the rat pituitary. In: Endocrinology. 2000 ; Vol. 141, No. 6. pp. 2084-2089.
@article{1904d817f65a417db4b98a4130bf0787,
title = "High plasma growth hormone (GH) levels inhibit expression of GH secretagogue receptor messenger ribonucleic acid levels in the rat pituitary",
abstract = "Synthetic GH secretagogues (GHSs) act via a receptor (GHS-R) distinct from that of GH-releasing hormone. The GHS-R has been cloned from the pituitary and is expressed not only in the pituitary but also in specific areas of the brain, including the hypothalamus. Recent studies suggest that hypothalamic GHS-R expression is regulated by GH. This study was designed to investigate whether pituitary GHS-R expression is modulated by GH. Female Wistar-Furth rats were injected sc with either saline (control) or GC tumor cells (GC) that secrete rat GH. The tumors were allowed to develop for 1-4 weeks. At weeks 1-4, control (n = 4-8) and GC rats (n = 3-8) were killed. Pituitary GHS-R messenger RNA (mRNA) was measured by a quantitative competitive PCR assay. The endogenous GHS-R mRNA levels were measured by determining the amount of competitive template RNA required to produce equimolar amounts of native and competitive template PCR products. The mean log plasma GH levels were significantly greater in the GC rat group than in the control group at weeks 2, 3, and 4. At these times, the mean log pituitary GHS-R mRNA contents were significantly lower in the GC rat group than in the control group. No relationship could be established between log estradiol levels and GHS-R levels. These data indicate that pituitary GHS-R expression is modulated by GH.",
author = "Ralf Nass and Joan Gilrain and Stacey Anderson and Bruce Gaylinn and Alan Dalkin and Richard Day and Mario Peruggia and Thorner, {Michael O.}",
year = "2000",
doi = "10.1210/en.141.6.2084",
language = "English (US)",
volume = "141",
pages = "2084--2089",
journal = "Endocrinology",
issn = "0013-7227",
publisher = "The Endocrine Society",
number = "6",

}

TY - JOUR

T1 - High plasma growth hormone (GH) levels inhibit expression of GH secretagogue receptor messenger ribonucleic acid levels in the rat pituitary

AU - Nass, Ralf

AU - Gilrain, Joan

AU - Anderson, Stacey

AU - Gaylinn, Bruce

AU - Dalkin, Alan

AU - Day, Richard

AU - Peruggia, Mario

AU - Thorner, Michael O.

PY - 2000

Y1 - 2000

N2 - Synthetic GH secretagogues (GHSs) act via a receptor (GHS-R) distinct from that of GH-releasing hormone. The GHS-R has been cloned from the pituitary and is expressed not only in the pituitary but also in specific areas of the brain, including the hypothalamus. Recent studies suggest that hypothalamic GHS-R expression is regulated by GH. This study was designed to investigate whether pituitary GHS-R expression is modulated by GH. Female Wistar-Furth rats were injected sc with either saline (control) or GC tumor cells (GC) that secrete rat GH. The tumors were allowed to develop for 1-4 weeks. At weeks 1-4, control (n = 4-8) and GC rats (n = 3-8) were killed. Pituitary GHS-R messenger RNA (mRNA) was measured by a quantitative competitive PCR assay. The endogenous GHS-R mRNA levels were measured by determining the amount of competitive template RNA required to produce equimolar amounts of native and competitive template PCR products. The mean log plasma GH levels were significantly greater in the GC rat group than in the control group at weeks 2, 3, and 4. At these times, the mean log pituitary GHS-R mRNA contents were significantly lower in the GC rat group than in the control group. No relationship could be established between log estradiol levels and GHS-R levels. These data indicate that pituitary GHS-R expression is modulated by GH.

AB - Synthetic GH secretagogues (GHSs) act via a receptor (GHS-R) distinct from that of GH-releasing hormone. The GHS-R has been cloned from the pituitary and is expressed not only in the pituitary but also in specific areas of the brain, including the hypothalamus. Recent studies suggest that hypothalamic GHS-R expression is regulated by GH. This study was designed to investigate whether pituitary GHS-R expression is modulated by GH. Female Wistar-Furth rats were injected sc with either saline (control) or GC tumor cells (GC) that secrete rat GH. The tumors were allowed to develop for 1-4 weeks. At weeks 1-4, control (n = 4-8) and GC rats (n = 3-8) were killed. Pituitary GHS-R messenger RNA (mRNA) was measured by a quantitative competitive PCR assay. The endogenous GHS-R mRNA levels were measured by determining the amount of competitive template RNA required to produce equimolar amounts of native and competitive template PCR products. The mean log plasma GH levels were significantly greater in the GC rat group than in the control group at weeks 2, 3, and 4. At these times, the mean log pituitary GHS-R mRNA contents were significantly lower in the GC rat group than in the control group. No relationship could be established between log estradiol levels and GHS-R levels. These data indicate that pituitary GHS-R expression is modulated by GH.

UR - http://www.scopus.com/inward/record.url?scp=0034455305&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034455305&partnerID=8YFLogxK

U2 - 10.1210/en.141.6.2084

DO - 10.1210/en.141.6.2084

M3 - Article

C2 - 10830294

AN - SCOPUS:0034455305

VL - 141

SP - 2084

EP - 2089

JO - Endocrinology

JF - Endocrinology

SN - 0013-7227

IS - 6

ER -